FIQLX Performance — Fidelity Japan Fund, Class Z
Data updated: 2026-09-23
FIQLX returned +20.90% year to date and +37.17% over one year to Jul 2026. Annualised returns are +19.92% over 3 years and +9.84% over 5 years. The fund beat its Japan Equity category average: $100 invested three years ago grew to $172, against $170 for the category, and to $137 over one year, against $131. Volatility over the past three years was 16.29% a year. In the 12 months to Jul 2026 the fund took in a net $78.7M, and assets reached $1.07B.
FIQLX Growth of $100
What $100 invested in Fidelity Japan Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Japan Equity category average over the same months.
| Period | FIQLX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $137 | $131 |
| 3 years (Aug 2023 – Jul 2026) | $172 | $170 |
| 5 years (Aug 2021 – Jul 2026) | $160 | $168 |
| Since data start (Aug 2019 – Jul 2026) | $223 | $212 |
FIQLX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +20.90% |
| 1 year | +37.17% |
| 3 years (annualised) | +19.92% |
| 5 years (annualised) | +9.84% |
FIQLX Annual Returns
Calendar-year total returns of Fidelity Japan Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +20.90% |
| 2025 | +31.90% |
| 2024 | +7.52% |
| 2023 | +16.10% |
| 2022 | −22.21% |
| 2021 | +3.22% |
| 2020 | +25.57% |
| 2019 (Aug–Dec) | +10.91% |
FIQLX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +7.8% | +9.0% | −9.7% | +10.7% | +6.1% | +0.9% | −4.0% | — | — | — | — | — |
| 2025 | +1.5% | +0.2% | +0.1% | +3.8% | +6.9% | +4.4% | −1.4% | +5.8% | +3.8% | +4.3% | −0.9% | 0.0% |
| 2024 | −0.7% | +3.7% | +2.7% | −5.8% | +3.3% | +1.8% | +6.9% | +3.0% | −0.1% | −5.5% | +1.8% | −3.1% |
| 2023 | +7.9% | −4.6% | +4.4% | −0.3% | +1.8% | +3.0% | +2.9% | −3.9% | −3.7% | −4.4% | +8.4% | +4.9% |
| 2022 | −8.1% | −2.8% | −2.5% | −8.8% | +3.1% | −9.2% | +7.3% | −3.3% | −9.8% | +3.6% | +12.6% | −4.1% |
| 2021 | −1.5% | +1.1% | +0.9% | −1.5% | +1.2% | −0.4% | +0.2% | +3.9% | +2.1% | −1.0% | −1.4% | −0.2% |
| 2020 | −3.3% | −7.1% | −9.0% | +8.4% | +7.6% | +1.6% | +1.5% | +6.5% | +4.0% | −0.8% | +11.5% | +4.3% |
| 2019 | — | — | — | — | — | — | — | −0.5% | +3.2% | +3.8% | +2.0% | +2.0% |
FIQLX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 16.29%
- 3-year Sharpe ratio: 0.95 (vs 4.5% risk-free rate)
- Best month: +10.70% (Apr 2026)
- Worst month: −9.67% (Mar 2026)
FIQLX Fund Flows
Monthly money in and out of Fidelity Japan Fund, from SEC Form N-PORT.
- 12-month net flow: $78.7M
- 12-month gross sales (incl. reinvestments): $221.3M
- Sales ÷ redemptions: 1.55×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $14.4M | $14.3M | $112K |
| Jun 2026 | $16.6M | $12.6M | $4.0M |
| May 2026 | $13.5M | $10.9M | $2.6M |
| Apr 2026 | $13.7M | $12.1M | $1.5M |
| Mar 2026 | $32.1M | $20.4M | $11.7M |
| Feb 2026 | $33.3M | $20.3M | $13.0M |
| Jan 2026 | $16.7M | $10.1M | $6.6M |
| Dec 2025 | $39.2M | $16.1M | $23.1M |
| Nov 2025 | $9.7M | $8.5M | $1.2M |
| Oct 2025 | $13.7M | $8.0M | $5.7M |
| Sep 2025 | $7.9M | $4.9M | $3.0M |
| Aug 2025 | $10.5M | $4.5M | $6.1M |
FIQLX Assets Under Management
Net assets of Fidelity Japan Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $1.07B |
| 2026-04-30 | $1.04B |
| 2026-01-31 | $925.30M |
| 2025-10-31 | $917.73M |
| 2025-07-31 | $787.97M |
| 2025-04-30 | $710.40M |
| 2025-01-31 | $678.85M |
| 2024-10-31 | $693.02M |
| 2024-07-31 | $719.99M |
| 2024-04-30 | $643.67M |
| 2024-01-31 | $644.34M |
| 2023-10-31 | $632.42M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.